Skip to content
Homepage
Author:
StarkAge Therapeutics
Posted Date:
April 16, 2026
New Preclinical Data on STX-1, a First-in-Class Senolytic ADC, To Be Presented at AACR 2026
StarkAge Therapeutics
April 16, 2026
StarkAge Therapeutics Announces Research Collaboration with Gustave Roussy to Advance Senolytic Therapies in Digestive Cancers
StarkAge Therapeutics
January 28, 2026
